The iconic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader market now raises questions about long-term returns . Copycat versions are diminishing exclusivity , prompting anxieties that betting on companies closely tied to Viagra's former standing could be a speculative strategy, especi